Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy
PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment
60
Participants
Timeline
Start Date
December 31, 2002
Study Completion Date
June 30, 2007
Conditions
Stress Disorders, Post-Traumatic
Interventions
BEHAVIORAL
Prolonged Exposure Therapy
DRUG
Paroxetine-CR
Trial Locations (1)
02114
Massachusetts General Hospital, Boston
All Listed Sponsors
lead
Massachusetts General Hospital
OTHER
NCT00121888 - Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy | Biotech Hunter | Biotech Hunter